BACKGROUND: Severe hemorrhagic shock and resuscitation initiates a dysfunctional systemic inflammatory response leading to end-organ injury. Clinical evidence supports the transfusion of high ratios of plasma and packed red blood cells (pRBCs) in the treatment of hemorrhagic shock. The effects of resuscitation with different ratios of fresh blood products on inflammation and organ injury have not yet been characterized. MATERIALS AND METHODS: Mice underwent femoral artery cannulation and pressure-controlled hemorrhage for 60 min, then resuscitation with fresh plasma and pRBCs collected from donor mice. Plasma alone, pRBCs alone, and ratios of 2:1, 1:1, and 1:2 plasma:pRBCs were used for resuscitation strategies. Mice were sacrificed to determine biochemical and hematologic parameters, serum cytokine concentrations, tissue myeloperoxidase levels, and vascular permeability. RESULTS: Compared with other resuscitation strategies, mice resuscitated with pRBCs alone exhibited increased hemoglobin levels, while other hematologic and biochemical parameters were not significantly different among groups. Compared with 1:1, mice resuscitated with varying ratios of plasma:pRBCs exhibited increased cytokine concentrations of KC, MIP-1α, and MIP-2, and increased intestinal and lung myeloperoxidase levels. Mice resuscitated with 1:1 had decreased vascular permeability in the intestine and lung as compared with other groups. CONCLUSIONS: Resuscitation with a 1:1 ratio of fresh plasma:pRBCs results in decreased systemic inflammation and attenuated organ injury. These findings support the potential advantage of transfusing blood products in physiologic ratios to improve the treatment of severe hemorrhagic shock.
BACKGROUND: Severe hemorrhagic shock and resuscitation initiates a dysfunctional systemic inflammatory response leading to end-organ injury. Clinical evidence supports the transfusion of high ratios of plasma and packed red blood cells (pRBCs) in the treatment of hemorrhagic shock. The effects of resuscitation with different ratios of fresh blood products on inflammation and organ injury have not yet been characterized. MATERIALS AND METHODS:Mice underwent femoral artery cannulation and pressure-controlled hemorrhage for 60 min, then resuscitation with fresh plasma and pRBCs collected from donormice. Plasma alone, pRBCs alone, and ratios of 2:1, 1:1, and 1:2 plasma:pRBCs were used for resuscitation strategies. Mice were sacrificed to determine biochemical and hematologic parameters, serum cytokine concentrations, tissue myeloperoxidase levels, and vascular permeability. RESULTS: Compared with other resuscitation strategies, mice resuscitated with pRBCs alone exhibited increased hemoglobin levels, while other hematologic and biochemical parameters were not significantly different among groups. Compared with 1:1, mice resuscitated with varying ratios of plasma:pRBCs exhibited increased cytokine concentrations of KC, MIP-1α, and MIP-2, and increased intestinal and lung myeloperoxidase levels. Mice resuscitated with 1:1 had decreased vascular permeability in the intestine and lung as compared with other groups. CONCLUSIONS: Resuscitation with a 1:1 ratio of fresh plasma:pRBCs results in decreased systemic inflammation and attenuated organ injury. These findings support the potential advantage of transfusing blood products in physiologic ratios to improve the treatment of severe hemorrhagic shock.
Authors: Joanne L Lomas; Chun-Shiang Chung; Patricia S Grutkoski; Brian W LeBlanc; Liz Lavigne; Jonathan Reichner; Stephen H Gregory; Lesley A Doughty; William G Cioffi; Alfred Ayala Journal: Shock Date: 2003-04 Impact factor: 3.454
Authors: T P Shanley; B A Davidson; N D Nader; N Bless; N Vasi; P A Ward; K J Johnson; P R Knight Journal: Crit Care Med Date: 2000-07 Impact factor: 7.598
Authors: S Chollet-Martin; P Montravers; C Gibert; C Elbim; J M Desmonts; J Y Fagon; M A Gougerot-Pocidalo Journal: Infect Immun Date: 1993-11 Impact factor: 3.441
Authors: Jason L Sperry; Juan B Ochoa; Scott R Gunn; Louis H Alarcon; Joseph P Minei; Joseph Cuschieri; Matthew R Rosengart; Ronald V Maier; Timothy R Billiar; Andrew B Peitzman; Ernest E Moore Journal: J Trauma Date: 2008-11
Authors: Ryan Stapley; Cilina Rodriguez; Joo-Yeun Oh; Jaideep Honavar; Angela Brandon; Brant M Wagener; Marisa B Marques; Jordan A Weinberg; Jeffrey D Kerby; Jean-Francois Pittet; Rakesh P Patel Journal: Free Radic Biol Med Date: 2015-04-29 Impact factor: 7.376
Authors: Ritha M Belizaire; Priya S Prakash; Jillian R Richter; Bryce R Robinson; Michael J Edwards; Charles C Caldwell; Alex B Lentsch; Timothy A Pritts Journal: J Am Coll Surg Date: 2012-02-17 Impact factor: 6.113
Authors: Alex L Chang; Young Kim; Aaron P Seitz; Rebecca M Schuster; Alex B Lentsch; Timothy A Pritts Journal: Shock Date: 2017-05 Impact factor: 3.454
Authors: Amy T Makley; Ritha Belizaire; Eric M Campion; Michael D Goodman; Dennis I Sonnier; Lou Ann Friend; Rebecca M Schuster; Stephanie R Bailey; Jay A Johannigman; Warren C Dorlac; Alex B Lentsch; Timothy A Pritts Journal: Mil Med Date: 2012-08 Impact factor: 1.437
Authors: Jillian R Richter; Jeffrey M Sutton; Ritha M Belizaire; Lou Ann Friend; Rebecca M Schuster; Taylor A Johannigman; Steven G Miller; Alex B Lentsch; Timothy A Pritts Journal: Shock Date: 2014-12 Impact factor: 3.454
Authors: Judith S Mercer; Debra A Erickson-Owens; Betty R Vohr; Richard J Tucker; Ashley B Parker; William Oh; James F Padbury Journal: J Pediatr Date: 2015-11-04 Impact factor: 4.406
Authors: Young Kim; Michael D Goodman; Andrew D Jung; William A Abplanalp; Rebecca M Schuster; Charles C Caldwell; Alex B Lentsch; Timothy A Pritts Journal: Thromb Res Date: 2019-11-26 Impact factor: 3.944
Authors: Nadine Beckmann; Jeffrey M Sutton; Richard S Hoehn; Peter L Jernigan; Lou Ann Friend; Taylor A Johanningman; Rebecca M Schuster; Alex B Lentsch; Charles C Caldwell; Timothy A Pritts Journal: Am J Physiol Lung Cell Mol Physiol Date: 2020-02-26 Impact factor: 5.464